Kenneth P. Olive

15.3k total citations · 3 hit papers
75 papers, 6.3k citations indexed

About

Kenneth P. Olive is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kenneth P. Olive has authored 75 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 25 papers in Molecular Biology and 24 papers in Cancer Research. Recurrent topics in Kenneth P. Olive's work include Pancreatic and Hepatic Oncology Research (36 papers), Cancer Cells and Metastasis (16 papers) and Cancer Genomics and Diagnostics (16 papers). Kenneth P. Olive is often cited by papers focused on Pancreatic and Hepatic Oncology Research (36 papers), Cancer Cells and Metastasis (16 papers) and Cancer Genomics and Diagnostics (16 papers). Kenneth P. Olive collaborates with scholars based in United States, Germany and United Kingdom. Kenneth P. Olive's co-authors include David A. Tuveson, Paul E. Oberstein, Tyler Jacks, Roderick T. Bronson, Denise Crowley, C. Benedikt Westphalen, Stephen A. Sastra, Bob Yin, Nicholas A. Willis and Zachary C. Ruhe and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Kenneth P. Olive

70 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

2014 1.5k citations Paul E. Oberstein, Carmine F. Palermo et al. profile →
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome

2004 974 citations Kenneth P. Olive et al. profile →
Stromal biology and therapy in pancreatic cancer

2010 604 citations Kenneth P. Olive et al. Gut profile →

Peers

Countries citing papers authored by Kenneth P. Olive

Since Specialization

Citations

This map shows the geographic impact of Kenneth P. Olive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth P. Olive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth P. Olive more than expected).

Fields of papers citing papers by Kenneth P. Olive

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth P. Olive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth P. Olive. The network helps show where Kenneth P. Olive may publish in the future.

Co-authorship network of co-authors of Kenneth P. Olive

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth P. Olive. A scholar is included among the top collaborators of Kenneth P. Olive based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth P. Olive. Kenneth P. Olive is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract PR05: CheMo4METPANC: Combination Chemotherapy (gemcitabine and nab-paclitaxel), chemokine (C-X-C) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in METastatic treatment-naïve PANCreatic adenocarcinoma 2024 ·Cancer Research ·Gulam A. Manji, Michael May, (unknown), Ilenia Pellicciotta, (unknown), (unknown), (unknown), (unknown), Kenneth P. Olive, Shikun Wang, Benjamin Izar, Ruth A. White, Susan E. Bates, Alexander G. Raufi	0
2	Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression 2023 ·Cancer Discovery ·(unknown), Amanda R. Decker-Farrell, Lukas Vlahos, (unknown), (unknown), H. Carlo Maurer, (unknown), Lorenzo Tomassoni, Stephen A. Sastra, Carmine F. Palermo, Tanner C. Dalton, Alice Ma, Fangda Li, Ezequiel J. Tolosa, Hanina Hibshoosh, Martín E. Fernández-Zapico, Alexander Muir, Andrea Califano, Kenneth P. Olive	11
3	Comprehensive DNA Methylation Analysis Indicates That Pancreatic Intraepithelial Neoplasia Lesions Are Acinar-Derived and Epigenetically Primed for Carcinogenesis 2023 ·Cancer Research ·(unknown), (unknown), H. Carlo Maurer, Adrian Idrizi, Kasper D. Hansen, Elizabeth D. Thompson, (unknown), Ralph H. Hruban, Kenneth P. Olive, Andrew P. Feinberg	11
4	Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanism 2023 ·Nature Cancer ·Zhenyi Su, Ning Kon, Jingjie Yi, Haiqing Zhao, Wanwei Zhang, Qiaosi Tang, Huan Li, Hiroki Kobayashi, Zhiming Li, Shoufu Duan, Yanqing Liu, Kenneth P. Olive, Zhiguo Zhang, Barry Honig, James J. Manfredi, Anil K. Rustgi, Wei Gu	36
5	Abstract LB_C03: Protein translation inhibition enforces histone deacetylase inhibitor activity resulting in synergistic pancreatic cancer cell death 2023 ·Molecular Cancer Therapeutics ·(unknown), Luigi Scotto, Agnès Basseville, Thomas Litman, (unknown), (unknown), (unknown), (unknown), (unknown), Kenneth G. Hull, Kenneth P. Olive, Antonio Tito Fojo, Daniel Romo, Susan E. Bates	1
6	High-speed light-sheet microscopy for the in-situ acquisition of volumetric histological images of living tissue 2022 ·Nature Biomedical Engineering ·Kripa Patel, Wenxuan Liang, Malte Casper, Venkatakaushik Voleti, Wenze Li, (unknown), Hanzhi Zhao, Citlali Pérez Campos, (unknown), (unknown), Elizabeth Philipone, Angela J. Yoon, Kenneth P. Olive, Shana M. Coley, Elizabeth M. C. Hillman	44
7	Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer 2022 ·PLoS Genetics ·Michael K. Scales, Ashley Velez-Delgado, Nina G. Steele, (unknown), (unknown), Wei Yan, (unknown), Zeribe C. Nwosu, Craig Johnson, Yaqing Zhang, (unknown), Rosa E. Menjivar, H. Carlo Maurer, Howard C. Crawford, Filip Bednar, Kenneth P. Olive, Marina Pasca di Magliano, Benjamin L. Allen	18
8	HIF-2α activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron 2021 ·Journal of Clinical Investigation ·Rashi Singhal, (unknown), Nupur K. Das, Samuel A. Kerk, Peter Sajjakulnukit, Sumeet Solanki, Anthony Andren, Roshan Kumar, Kenneth P. Olive, Ruma Banerjee, Costas A. Lyssiotis, Yatrik M. Shah	147
9	PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer 2021 ·JCI Insight ·(unknown), Sebastian Lange, H. Carlo Maurer, Kenneth P. Olive, Rickmer Braren, Nicole Pfarr, (unknown), Alexander Muckenhuber, Moritz Jesinghaus, Katja Steiger, Wilko Weichert, Helmut Friess, Roland M. Schmid, Hana Algül, Philipp J. Jost, Juliane Ramser, Christine Fischer, Anne S. Quante, Maximilian Reichert, Michael Quante	7
10	CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma 2020 ·Clinical Cancer Research ·Andrew Cannon, Christopher M. Thompson, H. Carlo Maurer, Pranita Atri, Rakesh Bhatia, (unknown), Dario Ghersi, Kenneth P. Olive, Sushil Kumar, Surinder K. Batra	15
11	The vascular landscape of human cancer 2020 ·Journal of Clinical Investigation ·Benjamin Kahn, Alfredo Lucas, (unknown), (unknown), Gregory W. Schwartz, Jinyang Li, (unknown), H. Carlo Maurer, Kenneth P. Olive, Robert B. Faryabi, Ben Z. Stanger	30
12	Harmonic Motion Imaging of Pancreatic Tumor Stiffness Indicates Disease State and Treatment Response 2019 ·Clinical Cancer Research ·Thomas Payen, Paul E. Oberstein, (unknown), Carmine F. Palermo, Stephen A. Sastra, Yang Han, Alireza Nabavizadeh, Irina R. Sagalovskiy, Barbara Orelli, (unknown), (unknown), Helen Remotti, Michael D. Kluger, Beth Schrope, John A. Chabot, Alina C. Iuga, Elisa E. Konofagou, Kenneth P. Olive	37
13	Effective Delivery of a Microtubule Polymerization Inhibitor Synergizes with Standard Regimens in Models of Pancreatic Ductal Adenocarcinoma 2019 ·Clinical Cancer Research ·(unknown), Irina R. Sagalovskiy, H. Carlo Maurer, Stephen A. Sastra, Carmine F. Palermo, Amanda R. Decker-Farrell, Min Jung Kim, Josephine Sheedy, Anna Mollin, Liangxian Cao, Jianhua Hu, Arthur Branstrom, Marla Weetall, Kenneth P. Olive	18
14	Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma 2018 ·Gut ·Luís Arnes, Zhaoqi Liu, Jiguang Wang, H. Carlo Maurer, Irina R. Sagalovskiy, Marta Sánchez-Martín, Nikhil Bommakanti, (unknown), Dina Balderes, Lori Sussel, Kenneth P. Olive, Raúl Rabadán	39
15	Current and Emerging Therapies in Metastatic Pancreatic Cancer 2017 ·Clinical Cancer Research ·Gulam A. Manji, Kenneth P. Olive, Yvonne M. Saenger, Paul E. Oberstein	117
16	Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma 2015 ·Clinical Cancer Research ·Salvia Jain, (unknown), Kelly Zullo, Luigi Scotto, Carmine F. Palermo, Stephen A. Sastra, Kenneth P. Olive, Serge Cremers, Tiffany Thomas, (unknown), Yuan Zhang, Govind Bhagat, Jennifer E. Amengual, Changchun Deng, Charles Karan, Ronald Realubit, Susan E. Bates, Owen A. O’Connor	49
17	Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism 2015 ·Carcinogenesis ·Filip Bednar, Heather Schofield, Meredith A. Collins, Wei Yan, Yaqing Zhang, Nikhil Shyam, (unknown), Luciana L. Almada, Kenneth P. Olive, Nabeel Bardeesy, Martín E. Fernández-Zapico, Daisuke Nakada, Diane M. Simeone, Sean J. Morrison, Marina Pasca di Magliano	21
18	Mouse models of cancer : a laboratory manual 2014 ·Cory Abate‐Shen, Katerina Politi, Lewis A. Chodosh, Kenneth P. Olive	4
19	Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma 2012 ·Cancer Research ·Reena Shakya, Tamas A. Gonda, Michael Quante, Martha Salas, Samuel Kim, (unknown), Steffen Hirsch, Justine Davies, (unknown), Kenneth P. Olive, Timothy C. Wang, Matthias Szabolcs, Benjamin Tycko, Thomas Ludwig	62
20	Heterozygosity for Hypoxia Inducible Factor 1α Decreases the Incidence of Thymic Lymphomas in a p53 Mutant Mouse Model 2009 ·Cancer Research ·Jessica A. Bertout, Shetal Patel, Benjamin H. Fryer, Amy C. Durham, Kelly L. Covello, Kenneth P. Olive, Michael H. Goldschmidt, M. Celeste Simon	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact